Attached files
file | filename |
---|---|
EX-31.2 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | sonoma_10k-3102.htm |
EX-31.1 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | sonoma_10k-3101.htm |
EX-23.1 - CONSENT - Sonoma Pharmaceuticals, Inc. | sonoma_10k-2301.htm |
EX-10.39 - STANDARD COMMERCIAL LEASE - Sonoma Pharmaceuticals, Inc. | sonoma_10k-1039.htm |
10-K - FORM 10-K - Sonoma Pharmaceuticals, Inc. | sonoma_10k-033118.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:
The Annual Report on Form 10-K for the year ended March 31, 2018 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 26, 2018 | By: | /s/ Jim Schutz | |
Jim Schutz Chief Executive Officer (Principal Executive Officer) |
|||
Date: June 26, 2018 | By: | /s/ Robert Miller | |
Robert Miller Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |